EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis



Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis



Official Gazette of the United States Patent & Trademark Office Patents 1258(3), May 21



A multi-valent immunogenic composition confers protection on an immunized host against infection caused by both Haemophilus influenzae and Moraxella catarrhalis. Such composition comprises at least four antigens comprising at least one antigen from Haemophilus influenzae, and at least one antigen from Moraxella catarrhalis. Three of the antigens are adhesins. High molecular weight (HMW) proteins and Haemophilus influenzae adhesin (Hia) proteins of non-typeable Haemophilus and a 200 kDa outer membrane protein of Moraxella catarrhalis comprise the adhesin components while the other antigen is a non-proteolytic analog of Hin47 protein. Each component does not impair the immunogenicity of the others. The multi-valent immunogenic composition may be combined with DTP component vaccines, which may also include non-virulent poliovirus and PRP-T, to provide a component vaccine without impairment of the immunogenic properties of the other antigens.

(PDF 0-2 workdays service: $29.90)

Accession: 035349077

Download citation: RISBibTeXText



Related references

Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis. Vaccine 25(25): 4801-4808, 2007

Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae. Official Gazette of the United States Patent & Trademark Office Patents 1254(5), Jan 29, 2002

Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. Journal of Infection and ChemoTherapy 20(2): 146-149, 2014

Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Review of Vaccines 4(6): 843-853, 2005

The other siblings: respiratory infections caused by Moraxella catarrhalis and Haemophilus influenzae. Current Infectious Disease Reports 8(3): 215-221, 2006

Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. Journal of Infectious Diseases 170(1): 220-222, 1994

Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 29(44): 7595-7598, 2012

Polyp and fibrous adhesion formation in acute otitis media caused by non-typeable or type b Haemophilus influenzae or Moraxella catarrhalis. Acta Oto-Laryngologica 120(7): 810-814, 2001

Adaptive bone modeling and remodeling in acute otitis media caused by non-typeable or type B Haemophilus influenzae or Moraxella catarrhalis. Acta Oto-Laryngologica 120(7): 815-820, 2001

Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study. Diagnostic Microbiology & Infectious Disease 37(3): 203-211, July, 2000

Development of antibody-dependent complement-mediated serum bactericidal assays for nontypeable Haemophilus influenzae and Moraxella catarrhalis for application in clinical vaccine trials. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 298, 1998

Higher serum levels of interleukin 10 occur at onset of acute otitis media caused by Streptococcus pneumoniae compared to Haemophilus influenzae and Moraxella catarrhalis. Laryngoscope 123(6): 1500-1505, 2013

Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia. Pediatric Infectious Disease Journal 35(6): 683-689, 2016

Seasonal patterns and association of meteorological factors with infection caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in childhood community-acquired pneumonia in a tropical region. Infectious Diseases: 1-4, 2016